RESEARCH PAPER
Coping strategies and their correlation with depression, anxiety, and stress among HIV-positive patients referred to voluntary counseling and testing center, Tehran, Iran, 2019
 
More details
Hide details
1
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
 
2
Bergen Addiction Research, Department of Addiction Medicine, Haukland University Hospital, Bergen, Norway
 
 
Submission date: 2021-08-20
 
 
Final revision date: 2021-11-02
 
 
Acceptance date: 2021-11-12
 
 
Publication date: 2023-09-15
 
 
HIV & AIDS Review 2023;22(3):251-260
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) is one of the major global health problems and stressful experience for individuals; therefore, different strategies are engaged to cope with the disease and associated problems. Each of these strategies may have different outcomes, including increased depression, anxiety, stress, and decreased social functioning, achieve full mental health, and social well-being. The aim of this study was to evaluate the coping strategies in HIV-positive patients, determine the prevalence of depression, anxiety, and stress in these patients as well as to investigate the relationship between coping strategies with the prevalence of depression, anxiety, and stress.

Material and methods:
In this study, 100 HIV-positive patients who were referred to voluntary counseling and testing (VCT) center from January to September 2019 were recruited by convenience sampling method to complete two validated questionnaires: ways of coping strategies (WOC) and depression, anxiety, and stress scale (DASS).

Results:
The findings showed that the mean score of emotion-focused and problem-focused strategies were 44.90 and 44.51, respectively. There was a significant relationship between problem-focused strategies and participants’ gender and both strategies with age of patients. The prevalence of depression, anxiety, and stress was 68%, 76%, and 73%, respectively. The prevalence of all three psychological conditions were correlated with gender. In addition, depression and anxiety were significantly correlated with the last educational level. Results also showed that using emotion-focused coping strategies was associated with depression, anxiety, and stress.

Conclusions:
Considering the study results, it seems necessary to conduct regular screening programs, appropriate psychological interventions, and social support for this population.

 
REFERENCES (43)
1.
Fauci AS, Folkers GK. Investing to meet the scientific challenges of HIV/AIDS. Health Aff (Millwood) 2009; 28: 1629-1641.
 
2.
The Joint United Nations Programme on HIV/AIDS (UNAIDS) data. Available from: https://www.unaids.org/en.
 
3.
Center for Communicable Diseases Control and Ministry of Health and Medical Education. Latest statistics on HIV infection in Islamic Republic of Iran, April to June 2017.
 
4.
Folkman S, Lazarus RS. An analysis of coping in a middle-aged community sample. J Health Soc Behav 1980; 21: 219-239.
 
5.
Jensen MP, Turner JA, Romano JM, Karoly P. Coping with chronic pain: a critical review of the literature. Pain 1991; 47: 249-283.
 
6.
World Health Organization. WHO summary brief on depression. Available from: http://www.who.int/mediacentre....
 
7.
O’Neill M. Sorochan J. Anxiety. In: Encyclopedia of Quality of Life and Well-Being Research. Michalos AC (ed.). Springer, Dordrecht 2014.
 
8.
Suzuki S, Ito D. Psychological stress. In: Encyclopedia of Behavioral Medicine. Gellman MD, Turner JR (eds.). Springer, New York 2013.
 
9.
Fink G. Stress: definition and history. In: Encyclopedia of Neuroscience. Elsevier Ltd. 2009; 549-555.
 
10.
Moradi G, Gouya MM, Dejman M, et al. Health needs of people living with HIV/AIDS: from the perspective of policy makers, physicians and consultants, and people living with HIV/AIDS. Iran J Public Health 2014; 43: 1424-1435.
 
11.
SeyedAlinaghi S, Paydary K, Afsar Kazerooni P, et al. Evaluation of stigma index among people living with HIV/AIDS (PLWHA) in six cities in Iran. Thrita 2013; 2: 69-75.
 
12.
Dejman M, Ardakani HM, Malekafzali B, et al. Psychological, social, and familial problems of people living with HIV/AIDS in Iran: a qualitative study. Int J Prev Med 2015; 6: 126.
 
13.
Padyab M, Ghazinour M, Richter J. Factor structure of the farsi version of the Ways of Coping Questionnaire. J Appl Soc Psychol 2012; 42: 2006-2018.
 
14.
Asghari Moghaddam MA, Saed F, Dibajnia P, Zangeneh J. A preliminary validation of the Depression, Anxiety and Stress Scales (DASS) in non-clinical sample. J Clin Psychol 2008; 6: 23-38.
 
15.
J Jozi ES, Entezar RK, Najafi Z, Eskandari S. Relation between personality dimensions, risk perception and coping strategies in people living with HIV. J Int Transl Med 2018; 6: 80-86.
 
16.
Hatamloo Sadabadi M, Babapour Kheirodin J. Comparison of quality of life and coping strategies in diabetic and non diabetic people. JSSU 2013; 20: 581-592.
 
17.
Rahimi R, Salimi Bajestani H. Personality factors and coping strategies based Problem solving and Emotion in men and women with and without type 2 diabetes. J N Khorasan Univ Med Sci 2017; 9: 75-88.
 
18.
Kaneez S. Depression and coping mechanism among HIV/AIDS patients under anti-retroviral therapy. Indian J Soc Psychiatry 2016; 32: 149-153.
 
19.
Oko R, Awosan K. Depression status, behavioral lifestyle and coping strategies among persons living with HIV/AIDS in Sokoto. Int J Med Health Res 2019; 1: 57-63.
 
20.
Talukdar A, Talukdar PS, Ghosal MK, Bal R, Ghosh P, Goswami DN. Evaluation of depression and coping skill among HIV-positive people in Kolkata, India. J Int Assoc Physicians AIDS Care (Chic) 2012; 11: 115-120.
 
21.
Chen D, Duan L, Chen X, et al. Coping strategies and associated factors among older Chinese people living with HIV/AIDS. Psychol Health Med 2020; 25: 898-907.
 
22.
Zhang X, Zhang X. Study on the influence of medical coping methods and social support on the quality of life in people living with HIV/AIDS. Chin J Dis Control 2011; 15: 777-780.
 
23.
Wani MA, Sankar R. Stress anxiety and depression among HIV/AIDS patients. Int J Indian Psychol 2015; 3: 87-97.
 
24.
Camara A, Sow MS, Touré A, et al. Anxiety and depression among HIV patients of the infectious disease department of Conakry University Hospital in 2018. Epidemiol Infect 2020; 148: e8.
 
25.
Kwakye A. Prevalence and impact of depression, anxiety and stress on CD4+ cell counts of HIV/AIDS patients receiving HAART in Ghana. J AIDS Clin Res 2018; 9: 2.
 
26.
Duko B, Toma A, Asnake S, Abraham Y. Depression, anxiety and their correlates among patients with HIV in South Ethiopia: an institution-based cross-sectional study. Front Psychiatry 2019; 10: 290.
 
27.
Amare T, Getinet W, Shumet S, Asrat B. Prevalence and associated factors of depression among PLHIV in Ethiopia: systematic review and meta-analysis, 2017. AIDS Res Treat 2018; 2018: 5462959-5462959.
 
28.
Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58: 721-728.
 
29.
Jeffrey A, Ciesla MA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001; 158: 725-730.
 
30.
Wang YY, Zhao J, Zhang Q, et al. Prevalence of depressive syndrome and their association with demographic and clinical characteristics in Chinese HIV patients. AIDS Care 2018; 30: 1388-1392.
 
31.
Su X, Lau JTF, Mak WWS, et al. Prevalence and associated factors of depression among people living with HIV in two cities in China. J Affect Disord 2013; 149: 108-115.
 
32.
Alinaghi SAS, Farhoudi B, Mohraz M, et al. Adherence to Antiretroviral therapy and tuberculosis treatment in a prison of Tehran, Iran. Infect Disord Drug Targets 2016; 16: 199-203.
 
33.
Yalda AR, Ali Naghi SAS, Abd Albaghi MH. Adherence to antiretroviral therapy and its determinants in AIDS patients: review article. Tehran Univ Med J 2008; 66: 447-455.
 
34.
Friedland J, Renwick R, McColl M. Coping and social support as determinants of quality of life in HIV/AIDS. AIDS Care 1996; 8: 15-32.
 
35.
Janssen RS, Holtgrave RD, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health 2001; 91: 1019-1024.
 
36.
Sherbourne CD, Hays RD, Fleishman JA et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry 2000; 157: 248-254.
 
37.
Razavi P, Hajifathalian K, Saeidi B, et al. Quality of life among persons with HIV/AIDS in Iran: internal reliability and validity of an international instrument and associated factors. AIDS Res Treat 2012; 2012: 849406. doi: 10.1155/2012/849406.
 
38.
Khalili H, Rohani R, Seyedalinaghi S, Hajiabdolbaghi M, Dashti-Khavidaki S, Talasaz AH. Adherence to antiretroviral therapy among Iranian HIV/AIDS patients. Curr Clin Pharmacol 2012; 7: 111-115.
 
39.
SeyedAlinaghi S, Jam S, Foroughi M, et al. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4+ T lymphocyte count and medical and psychological symptoms. Psychosom Med 2012; 74: 620-627.
 
40.
Emamzadeh-Fard S, Fard SE, SeyedAlinaghi S, Paydary K. Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: a review. Infect Disord Drug Targets 2012; 12: 346-356.
 
41.
Zandmomen Z, Sardashti S, Firouzeh MM, et al. Addressing predictors of HIV related risk behaviors: demographic and psychosocial profile of Iranian patients. J Infect Public Health 2014; 7: 472-480.
 
42.
Paydary K, Ekhtiari H, Noori M, Rad MV, Hajiabdolbaghi M, Seyed¬Alinaghi S. Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients. Infect Disord Drug Targets 2015; 15: 177-183.
 
43.
Paydary K, Mahin Torabi S, SeyedAlinaghi S, et al. Impulsivity, sensation seeking, and risk-taking behaviors among HIV-positive and HIV-negative heroin dependent persons. AIDS Res Treat 2016; 2016: 5323256. doi: 10.1155/2016/5323256.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top